Povero M, Castello L, Pradelli L, et al. [Cost per Responder Analysis of Filgotinib in Patients Suffering from Ulcerative Colitis]. Farmeconomia. Health Economics and Therapeutic Pathways. 2024;25(1). https://doi.org/10.7175/fe.v25i1.1554